HRP20110254T1 - Promotori mutantne aox1 - Google Patents

Promotori mutantne aox1 Download PDF

Info

Publication number
HRP20110254T1
HRP20110254T1 HR20110254T HRP20110254T HRP20110254T1 HR P20110254 T1 HRP20110254 T1 HR P20110254T1 HR 20110254 T HR20110254 T HR 20110254T HR P20110254 T HRP20110254 T HR P20110254T HR P20110254 T1 HRP20110254 T1 HR P20110254T1
Authority
HR
Croatia
Prior art keywords
nucleotides
nucleic acid
cell
promoter
seq
Prior art date
Application number
HR20110254T
Other languages
English (en)
Inventor
Hartner Franz
Glieder Anton
Original Assignee
Technische Universitt Graz
Vtu Holding Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technische Universitt Graz, Vtu Holding Gmbh filed Critical Technische Universitt Graz
Publication of HRP20110254T1 publication Critical patent/HRP20110254T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/03Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
    • C12Y101/03013Alcohol oxidase (1.1.3.13)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Promotor alkoholne oksidaze 1 mutantne Pichia pastoris (AOX1), kao promotor divljeg tipa Pichia pastoris AOX1 (SEQ ID No.1) naznačen time, da sadrži najmanje jednu mutaciju unutar nukleotida 694 do 723 (-260 do -231) od SEQ ID No.1 za visoku ekspresiju pod uvjetima derepresije u odnosu na promotor AOX1 divljeg tipa. Patent sadrži još 18 patentnih zahtjeva.

Claims (19)

1. Promotor alkoholne oksidaze 1 mutantne Pichia pastoris (AOX1), kao promotor divljeg tipa Pichia pastoris AOX1 (SEQ ID No.1) naznačen time, da sadrži najmanje jednu mutaciju unutar nukleotida 694 do 723 (-260 do -231) od SEQ ID No.1 za visoku ekspresiju pod uvjetima derepresije u odnosu na promotor AOX1 divljeg tipa.
2. Promotor prema zahtjevu 1, naznačen time, da promotor sadrži nadalje mutaciju nukleotida 170-239 (-784 do -719) i/ili nukleotida 729 do 763 (-225 do -191) od SEQ ID No.1 i/ili od faktora transkripcije na mjestu vezivanja (TFBS) i/ili najmanje jednu mutaciju odabranu iz skupine koja sadrži nukleotide 170 do 191 (-784 do -763), nukleotide 192 do 213 (-762 do -741), nukleotide 192 do 210 (-762 do -744), nukleotide 207 do 209 (-747 do -745), nukleotide 214 do 235 (-740 do -719), nukleotide 304 do 350 (-650 do -604), nukleotide 364 do 393 (-590 do -561), nukleotide 434 do 508 (-520 do -446), nukleotide 509 do 551 (-445 do -403), nukleotide 552 do 560 (-402 do -394), nukleotide 585 do 617 (-369 do -337), nukleotide 621 do 660 (-333 do -294), nukleotide 625 do 683 (-329 do -271), nukleotide 736 do 741 (-218 do -213), nukleotide 737 do 738 (-217 do -216), nukleotide 726 do 755 (-228 do -199), nukleotide 784 do 800 (-170 do -154) ili nukleotide 823 do 861 (-131 do -93).
3. Promotor prema zahtjevu 1 ili 2, naznačen time, da mutacija je izbacivanje, supstitucija, umetanje i/ili inverzija.
4. Promotor prema zahtjevu 2 ili 3, naznačen time, da je faktor transkripcije na mjestu spajanja (TFBS) odabran iz skupine koja sadrži Hap1, Hsf, Hap234, abaA, Stre, Rap1, Adr1, Mat1MC, Gcr1 i QA-1F, pri čemu faktor transkripcije na mjestu spajanja (TFBS) Hap1 sadrži prednosno nekleotide 54 do 58 od SEQ ID No.1, Hsf nukleotide 142 do 149 i 517 do 524 od SEQ ID No.1, Hap234 nukleotide 196 do 200, 206 do 210 i 668 do 672 od SEQ ID No.1, abaA nukleotide 219 do 224 od SEQ ID No.1, Stre nukleotide 281 do 285 od SEQ ID No.1, Rap1 nukleotide 335 do 339 od SEQ ID No.1, Adr1 nukleotide 371 do 377 od SEQ ID No.1, Mat1MC nukleotide 683 do 687 od SEQ ID No.1, Gcr1 nukleotide 702 do 706 od SEQ ID No.1 i QA-1F nukleotide 747 do 761 od SEQ ID No.1.
5. Molekula nukleinske kiseline koja sadrži najmanje jedan promotor alkoholne oksidaze 1 mutantne Pichia pastoris (AOX1) prema bilo kojem zahtjevu 1 do 4, i najmanje jednu nukleinsku kiselinu koja kodira protein (peptid) ili funkcionalnu nukleinsku kiselinu, naznačena time, da su spomenuti promotor i spomenuta nukleinska kiselina operativno povezani zajedno formirajući jednostruku ili višestruku kopiju kasete ekspresije.
6. Vektor, naznačen time, da sadrži promotor alkoholne oksidaze 1 mutantne Pichia pastoris (AOX1) prema bilo kojem zahtjevu 1 do 4, ili molekulu nukleinske kiseline prema zahtjevu 5.
7. Stanica, naznačena time, da sadrži najmanje jedan promotor alkoholne oksidaze 1 mutantne Pichia pastoris (AOX1) prema bilo kojem zahtjevu 1 do 4, najmanje jedan fragment nukleinske kiseline prema zahtjevu 5 ili najmanje jedan vektor prema zahtjevu 6.
8. Stanica prema zahtjevu 7, naznačena time, da spomenuta stanica je eukariotska stanica, posebno stanica kvasca, prednosno metilotrofička stanica kvasca, najbolje odabrana iz skupine koja se sastoji od stanica Candida, Hansenula, Pichia i Toruplosis, posebno stanica Pichia pastoris.
9. Garnitura za ekspresiju odabranog proteina, naznačena time, da sadrži vektor prema zahtjevu 6, i stanicu sposobnu za ekspresiju spomenutog proteina pod kontrolom promotora prema bilo kojem zahtjevu od 1 do 4.
10. Garnitura prema zahtjevu 9, naznačena time, da spomenuta stanica je stanica kvasca, najbolje metilotrofička stanica kvasca, prednosno odabrana iz skupine koja se sastoji od stanica Candida, Hansenula, Pichia i Toruplosis, posebno stanica Pichia pastoris.
11. Postupak ekspresije rekombinantnog proteina, peptida ili funkcionalne nukleinske kiseline u stanici, naznačen time, da sadrži sljedeće korake: dobavljanje molekule nukleinske kiseline prema zahtjevu 5 ili vektora prema zahtjevu 6 koji sadrži promotor AOX1 prema bilo kojem zahtjevu od 1 do 4 i nukleinsku kiselinu koja kodira za protein, peptid ili funkcionalnu nukleinsku kiselinu, pri čemu je spomenuti promotor operativno povezan na spomenutu nukleinsku kiselinu, transformiranje spomenute stanice sa spomenutim vektorom ili spomenutom molekulom nukleinske kiseline, uzgajanje transformirane stanice u pogodnom mediju za uzgoj, opcijski induciranje ekspresije spomenutog proteina, peptida ili funkcionalne nukleinske kiseline, i izoliranje spomenutog izraženog proteina, peptida ili funkcionalne nukleinske kiseline.
12. Postupak prema zahtjevu 11, naznačen time, da spomenuta stanica je stanica kvasca, najbolje metilotrofička stanica kvasca, prednosno odabrana iz skupine koja se sastoji od stanica Candida, Hansenula, Pichia i Toruplosis, posebno stanica Pichia pastoris.
13. Uporaba molekule nukleinske kiseline prema zahtjevu 5, vektora prema zahtjevu 6 ili stanice prema bilo kojem zahtjevu 7 ili 8, naznačena time, da je za ekspresiju proteina, peptida ili funkcionalne nukleinske kiseline.
14. Postupak izolacije prvorazredne ekspresije klonova, naznačen time, da sadrži sljedeće korake: uvođenje molekule nukleinske kiseline koja sadrži najmanje jednu mutaciju promotora alkoholne oksidaze 1 mutantne Pichia pastoris (AOX1) prema bilo kojem zahtjevu od 1 do 4 i najmanje jednu nukleinsku kiselinu koja kodira protein (peptid) ili funkcionalnu nukleinsku kiselinu i marker otpornosti gena, pri čemu su spomenuti promotor i spomenuta nukleinska kiselina operativno povezani zajedno formirajući jednostruku ili višestruku kopiju kasete ekspresije ili vektor koji sadrži molekulu nukleinske kiseline u stanici, prenošenje stanice iz koraka (a) u medij koji sadrži prikladan selektivni marker, neograničavajući izvor ugljika i metanol za selektivni rast klonova prvorazredne ekspresije pod uvjetima derepresije, inkubacija stanice iz koraka (b) na spomenutom mediju, izolacija kolonije stanica dobivenih iz koraka (c), otkrivanje klonova prvorazredne ekspresije određivanjem razmjera ekspresije spomenute stanice.
15. Postupak prema zahtjevu 14, naznačen time, da selektivni marker je antibiotik, prednosno Zeocin ili geneticin.
16. Postupak prema zahtjevu 14 ili 15, naznačen time, da selektivni marker je Zeocin i marker otpornosti gena je gen sh ble.
17. Postupak prema bilo kojem zahtjevu od 14 do 16, naznačen time, da stanica je stanica kvasca, prednosno metilotrofička stanica kvasca, najbolje odabrana iz skupine koja se sastoji od stanica Candida, Hansenula, Pichia i Toruplosis, posebno stanica Pichia pastoris.
18. Postupak prema bilo kojem zahtjevu od 11 do 17, naznačen time, da je neograničavajući izvor ugljika odabran iz skupine koja sadrži alanin, manitol, sorbitol, trehaloza, laktoza i njihova kombinacija.
19. Postupak prema bilo kojem zahtjevu od 11 do 18, naznačen time, da je molekula nukleinske kiseline ili vektor uveden u stanicu putem transformacije, najbolje elektroporacijom ili kemijskom transformacijom, ili putem protoplastičke fuzije, ili pomoću bombardiranja čestica.
HR20110254T 2005-02-23 2011-04-08 Promotori mutantne aox1 HRP20110254T1 (hr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0030405A AT501955B1 (de) 2005-02-23 2005-02-23 Mutierte aox1-promotoren

Publications (1)

Publication Number Publication Date
HRP20110254T1 true HRP20110254T1 (hr) 2011-05-31

Family

ID=36927772

Family Applications (2)

Application Number Title Priority Date Filing Date
HR20110084T HRP20110084T2 (hr) 2005-02-23 2011-02-03 Promotori mutantne aox1
HR20110254T HRP20110254T1 (hr) 2005-02-23 2011-04-08 Promotori mutantne aox1

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HR20110084T HRP20110084T2 (hr) 2005-02-23 2011-02-03 Promotori mutantne aox1

Country Status (21)

Country Link
US (2) US9012175B2 (hr)
EP (2) EP2199389B1 (hr)
JP (2) JP5497986B2 (hr)
KR (2) KR101352399B1 (hr)
CN (2) CN101128581B (hr)
AT (3) AT501955B1 (hr)
AU (2) AU2006216094B2 (hr)
BR (1) BRPI0606179B1 (hr)
CA (2) CA2785161C (hr)
DE (2) DE602006019789D1 (hr)
DK (2) DK2199389T3 (hr)
ES (2) ES2358086T3 (hr)
HK (2) HK1113172A1 (hr)
HR (2) HRP20110084T2 (hr)
IN (1) IN2012DN06694A (hr)
NZ (2) NZ560542A (hr)
PL (2) PL1851312T3 (hr)
PT (1) PT1851312E (hr)
SI (2) SI2199389T1 (hr)
UA (2) UA94399C2 (hr)
WO (1) WO2006089329A2 (hr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2271755B1 (en) * 2008-03-27 2017-03-22 E. I. du Pont de Nemours and Company High expression zymomonas promoters
WO2010004042A2 (en) * 2008-07-11 2010-01-14 Novozymes A/S Pichia pastoris das promoter variants
EP2258855A1 (en) 2009-05-28 2010-12-08 Universität für Bodenkultur Wien Expression sequences
WO2012129036A2 (en) * 2011-03-22 2012-09-27 Merck Sharp & Dohme Corp. Promoters for high level recombinant expression in fungal host cells
GB201113419D0 (en) * 2011-08-04 2011-09-21 Fujifilm Diosynth Biotechnologies Uk Ltd Yeast vector
EP2565262A1 (en) 2011-08-31 2013-03-06 VTU Holding GmbH Protein expression
KR101954389B1 (ko) * 2011-10-07 2019-03-06 론자 리미티드 조절가능한 프로모터
US9309523B2 (en) 2012-12-05 2016-04-12 Exxonmobil Research And Engineering Company Nannochloropsis kozak consensus sequence
EP3594351B1 (en) 2013-03-08 2021-09-29 Keck Graduate Institute of Applied Life Sciences Yeast promoters from pichia pastoris
CN105358706A (zh) * 2013-03-08 2016-02-24 生物语法公司 用于蛋白质表达的酵母启动子
EP2970994B1 (en) 2013-03-15 2019-07-17 Lonza Ltd Constitutive promoter
US9150870B2 (en) 2013-03-15 2015-10-06 Lonza Ltd. Constitutive promoter
US11518797B2 (en) 2014-11-11 2022-12-06 Clara Foods Co. Methods and compositions for egg white protein production
EP3294762B1 (en) 2015-05-11 2022-01-19 Impossible Foods Inc. Expression constructs and methods of genetically engineering methylotrophic yeast
KR102253479B1 (ko) 2015-08-05 2021-05-21 론자 리미티드 프로모터 변이체
CN108728477B (zh) * 2017-04-24 2022-02-22 华东理工大学 一种高效的转座突变系统及构建方法
AU2018291000B2 (en) * 2017-06-30 2022-10-27 Dow Global Technologies Llc Coating for aldehyde remediation and method of making
US11866714B2 (en) 2018-06-07 2024-01-09 Basf Se Promoter for yeast
JP2022501028A (ja) * 2018-09-24 2022-01-06 オルタ ドグ テクニク ユニヴェルシテシ プロモータ工学によるアルコールデヒドロゲナーゼ2(adh2)プロモータ変異体の設計
JP2022502018A (ja) * 2018-09-24 2022-01-11 オルタ ドグ テクニク ユニヴェルシテシ 改変されたaox1プロモータバリアント
CN110029122B (zh) * 2019-03-19 2022-03-01 青岛蔚蓝生物集团有限公司 一种甘露聚糖酶高产菌株及其应用
CN110029120B (zh) * 2019-03-19 2022-03-01 青岛蔚蓝生物集团有限公司 一种植酸酶高产菌株及其应用
CN109735547B (zh) * 2019-03-19 2022-05-31 青岛蔚蓝生物集团有限公司 一种提高毕赤酵母外源蛋白表达量的启动子及其应用
EP3956454A1 (en) * 2019-04-17 2022-02-23 Impossible Foods Inc. Materials and methods for protein production
CN110106168B (zh) * 2019-05-27 2021-07-13 西南大学 基于转录因子间的互作关系构建双激素响应启动子的方法
CN114375304A (zh) 2019-07-11 2022-04-19 克莱拉食品公司 蛋白质组合物及其食用品
US12096784B2 (en) 2019-07-11 2024-09-24 Clara Foods Co. Protein compositions and consumable products thereof
US10927360B1 (en) 2019-08-07 2021-02-23 Clara Foods Co. Compositions comprising digestive enzymes
CN110724720A (zh) * 2019-11-01 2020-01-24 山东仙普爱瑞科技股份有限公司 一种猪α-干扰素的发酵工艺
CN117120618A (zh) 2021-02-12 2023-11-24 勃林格殷格翰 Rcv 两合公司 用于增加蛋白质分泌的信号肽
CA3131181C (en) * 2021-06-24 2023-03-07 BioBoost Synbio Consulting Inc. Method for methanol free culturing of methylotrophic yeast for the biosynthesis of added value products
CN117417934B (zh) * 2023-10-27 2024-09-13 江南大学 跨菌种启动子、多菌种穿梭质粒及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2063890C (en) * 1991-03-27 2007-03-13 Masami Miura Mutant aox2 promoter, microorganism carrying same, method of preparation thereof and production of heterologous protein using such microorganism
CA2058820C (en) * 1991-04-25 2003-07-15 Kotikanyad Sreekrishna Expression cassettes and vectors for the secretion of human serum albumin in pichia pastoris cells
JPH06209763A (ja) * 1993-01-13 1994-08-02 Green Cross Corp:The 変異株
AU6415594A (en) * 1993-03-25 1994-10-11 Biosource Genetics Corporation (pichia pastoris) alcohol oxidase (zza1) and (zza2)
JP3290108B2 (ja) * 1997-08-29 2002-06-10 麒麟麦酒株式会社 プロモーター活性を増大させるdna配列
CN1192103C (zh) * 1998-01-27 2005-03-09 三井化学株式会社 生产植酸酶的方法
AU3910000A (en) * 1999-03-22 2000-10-09 Zymogenetics Inc. Improved methods for producing proteins in transformed (pichia)
CN1188524C (zh) * 2001-02-28 2005-02-09 珠江医院 人SP-A1在pichia pastoris中的表达
MXPA03009059A (es) * 2001-04-05 2004-10-15 Univ Nebraska Secuencias de nucleotidos reguladoras de alcohol oxidasa 1 para expresion de genes heterologos en levadura.
EP1431387B1 (en) * 2002-12-20 2008-02-27 Roche Diagnostics GmbH Heat-labile desoxyribonculease I variants

Also Published As

Publication number Publication date
BRPI0606179A2 (pt) 2009-06-02
UA94399C2 (ru) 2011-05-10
CN101128581A (zh) 2008-02-20
CN101935657A (zh) 2011-01-05
WO2006089329A2 (en) 2006-08-31
WO2006089329A8 (en) 2006-11-02
US20080153126A1 (en) 2008-06-26
CN101128581B (zh) 2012-04-18
AU2011200187B2 (en) 2012-01-19
IN2012DN06694A (hr) 2015-10-23
ES2356127T9 (es) 2011-05-30
CA2598514C (en) 2013-07-09
US9279129B2 (en) 2016-03-08
EP1851312A2 (en) 2007-11-07
US20100196913A1 (en) 2010-08-05
HRP20110084T2 (hr) 2011-10-31
DK1851312T5 (da) 2011-04-18
HK1148313A1 (en) 2011-09-02
ATE496125T1 (de) 2011-02-15
CA2785161A1 (en) 2006-08-31
SI2199389T1 (sl) 2011-05-31
CA2785161C (en) 2020-03-31
CA2598514A1 (en) 2006-08-31
AU2011200187A1 (en) 2011-02-03
KR101352399B1 (ko) 2014-02-18
KR101358663B1 (ko) 2014-02-20
DK1851312T3 (da) 2011-02-28
DK2199389T3 (da) 2011-04-11
EP1851312B1 (en) 2010-11-10
ES2358086T3 (es) 2011-05-05
HK1113172A1 (en) 2008-09-26
SI1851312T1 (sl) 2011-03-31
KR20120106979A (ko) 2012-09-27
ATE487788T1 (de) 2010-11-15
DE602006019789D1 (de) 2011-03-03
PT1851312E (pt) 2011-01-05
PL1851312T3 (pl) 2011-05-31
AT501955B1 (de) 2007-08-15
CN101935657B (zh) 2013-02-13
US9012175B2 (en) 2015-04-21
WO2006089329A3 (en) 2007-05-31
UA98604C2 (ru) 2012-05-25
JP5497986B2 (ja) 2014-05-21
EP2199389B1 (en) 2011-01-19
HRP20110084T1 (hr) 2011-03-31
AU2006216094A1 (en) 2006-08-31
NZ585821A (en) 2011-02-25
JP2012080886A (ja) 2012-04-26
NZ560542A (en) 2010-06-25
PL2199389T3 (pl) 2011-06-30
AT501955A1 (de) 2006-12-15
BRPI0606179B1 (pt) 2018-05-29
ES2356127T3 (es) 2011-04-05
JP5552107B2 (ja) 2014-07-16
JP2008531000A (ja) 2008-08-14
EP2199389A1 (en) 2010-06-23
DE602006018113D1 (de) 2010-12-23
KR20070107781A (ko) 2007-11-07
EP1851312B9 (en) 2011-04-20
AU2006216094B2 (en) 2010-10-21

Similar Documents

Publication Publication Date Title
HRP20110254T1 (hr) Promotori mutantne aox1
US9938327B2 (en) Expression constructs and methods of genetically engineering methylotrophic yeast
ES2902044T3 (es) Variantes de promotor
JP3592326B2 (ja) ユビキチン特異的プロテアーゼ
US8143023B2 (en) Method for methanol independent induction from methanol inducible promoters in Pichia
US12116699B2 (en) Materials and methods for protein production
EP2140008A2 (en) Yeast expression systems
CZ284017B6 (cs) Fragment DNA(L), kodující polypeptid s nitril-hydratasovou aktivitou, transformant, obsahující tento gen a způsob přípravy nitril-hydratasy a amidů použitím tohoto transformantu
CN112725210B (zh) 抑制乳酸代谢和乙醇产生的重组耐酸酵母及使用其生产乳酸的方法
US20230257793A1 (en) Synthetic expression systems
CN113528362A (zh) 甘油产生受到抑制的重组耐酸酵母和使用其生产乳酸的方法
US20080233614A1 (en) Production of recombinant collagenases colg and colh in escherichia coli
WO2020235692A1 (ja) 組換えミノムシ絹糸タンパク質の大量生産システム
US5622840A (en) Method for controlling gene expression
US9150870B2 (en) Constitutive promoter
US20210230573A1 (en) Microorganisms and the production of fine chemicals
CA2809828A1 (en) Regulatory element for heterologous protein production in the fruiting body of filamentous fungi
WO2017163946A1 (ja) 誘導型プロモーター
US20240002847A1 (en) Synthetic methanol inducible promoters and uses thereof
PT725822E (pt) Processo para preparacao de proteinas por recombinacao em leveduras
AU2021411733A9 (en) Novel yeast strains
KR101684489B1 (ko) 신규한 프로모터 및 이를 이용한 수소 생산 방법
KR20220136947A (ko) 고농도 co2 및/또는 산성에 대한 내성이 증진된 재조합 미세조류
Elias Characterization of ESl47, a salt stress regulated protein kinase from Lophopyrum elongatum
JP2006075123A (ja) キャンディダ・ユティリス由来のプロモーターdna